Abstract
Background: The balance between quality of life and aggressive treatment fuels strong debate in cancer care. Recently, more attention is focused on blending advanced care, palliative care and hospice treatments in a patient-specific, tailored manner. This case study explores quality of life, the role of psychosocial factors in treatment selection, and the role of medical bias in endof- life decision-making. Case Report: The patient was a 55-year-old woman with advanced recurrent epithelial ovarian cancer. The disease course was essentially unremitting with only 5 months of non-progression after initial treatment. Multiple courses of chemotherapy were provided, in addition to a wide range of advanced and aggressive therapies to treat the cancer, as well as prolong life. Hospice care was an active part of treatment over 2 separate time periods, with a 1-year hiatus between admissions into hospice care. Conclusion: This case study provides an example of blending aggressive treatment, palliative care and hospice care to allow a patient to achieve specific life milestones, while attempting to preserve quality of life.
Original language | English (US) |
---|---|
Pages (from-to) | 27-29 |
Number of pages | 3 |
Journal | Onkologie |
Volume | 29 |
Issue number | 1-2 |
DOIs | |
State | Published - Jan 2006 |
Externally published | Yes |
Keywords
- End-of-life decisions
- Hospice
- Medical decision-making
- Ovarian cancer
- Quality of life
ASJC Scopus subject areas
- Hematology
- Oncology
- Cancer Research